BioCryst Pharmaceuticals
BCRX
#5073
Rank
โ‚ฌ1.37 B
Marketcap
6,52ย โ‚ฌ
Share price
-3.07%
Change (1 day)
-9.49%
Change (1 year)

BioCryst Pharmaceuticals (BCRX) - Total assets

Total assets on the balance sheet as of September 2025 : โ‚ฌ0.38 Billion

According to BioCryst Pharmaceuticals 's latest financial reports the company's total assets are โ‚ฌ0.38 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

BioCryst Pharmaceuticals - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2024-12-31โ‚ฌ0.47 B0.78%
2023-12-31โ‚ฌ0.46 B-8.8%
2022-12-31โ‚ฌ0.51 B-1.27%
2021-12-31โ‚ฌ0.51 B90.84%
2020-12-31โ‚ฌ0.27 B73.92%
2019-12-31โ‚ฌ0.15 B21.9%
2018-12-31โ‚ฌ0.12 B-13.6%
2017-12-31โ‚ฌ0.14 B73.93%
2016-12-31โ‚ฌ85.41 M-23.67%
2015-12-31โ‚ฌ0.11 B-0.56%
2014-12-31โ‚ฌ0.11 B218.06%
2013-12-31โ‚ฌ35.38 M-18.51%
2012-12-31โ‚ฌ43.42 M-31.4%
2011-12-31โ‚ฌ63.3 M-23.07%
2010-12-31โ‚ฌ82.28 M-17.09%
2009-12-31โ‚ฌ99.24 M63.82%
2008-12-31โ‚ฌ60.58 M-38.02%
2007-12-31โ‚ฌ97.74 M88.32%
2006-12-31โ‚ฌ51.9 M-38.05%
2005-12-31โ‚ฌ83.78 M250.03%
2004-12-31โ‚ฌ23.93 M0.13%
2003-12-31โ‚ฌ23.9 M-39.5%
2002-12-31โ‚ฌ39.5 M-40.96%
2001-12-31โ‚ฌ66.91 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Repligen
RGEN
โ‚ฌ2.51 B 554.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
โ‚ฌ3.00 B 682.54%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
โ‚ฌ7.57 M-98.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
โ‚ฌ1.01 B 164.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚ฌ50.27 B 13,011.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
โ‚ฌ0.55 B 45.25%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚ฌ70.82 B 18,371.32%๐Ÿ‡ฌ๐Ÿ‡ง UK
Emergent BioSolutions
EBS
โ‚ฌ1.25 B 227.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
โ‚ฌ17.46 M-95.44%๐Ÿ‡บ๐Ÿ‡ธ USA